Abstract

Among a whole variety of EBV- and HHV6-linked diseases only infectious mononucleosis is subject to official statistical reporting in Russia that substantially complicates objective assessment of etiological structure, incidence rate, characteristics of developing epidemic process. Currently, the data on the genetic EBV heterogeneity, even at the level of the main types (EBV1 and EBV2), as well as HHV6A and HHV6B, prevalence and clinical importance are mainly limited to foreign research publications. Few publications assessing this issue are available in Russian scientific papers. At the same time, examining circulation of virus genetic types (variants) and use of such data in implementing epidemiological surveillance after some other infections have been commonly practiced. One of the key issues is the level of developed laboratory support for molecular genetic monitoring. The goal of the study was to improve methodological basics for differential detection of HHV6A/B and the major EBV types. There were used samples of peripheral blood leukocytes collected from children aged 1–15 years with acute (n = 50) and asymptomatic infectious mononucleosis (n = 29). The detection and quantification of EBV and HHV6 DNA was performed by using real-time PCR. For differential determination of EBV1/EBV2 and HHV6A/HHV6B, an optimized one-round PCR with electrophoretic agarose gel detection amplification products was used. The data from our own study showed that frequency of detected EBV and HHV6 DNA in acute infectious mononucleosis patients comprised 74 and 72% compared to control group reaching 35 and 74%, respectively. It was found that among the examined children of Nizhny Novgorod Region, EBV1 and HHV6B prevailed in the viral population that agrees with existing insights about their geographical distribution in the adjacent territories. EBV2 was found in a single sample only in the control group. HHV6A was not detected in any of the groups. The methodological approach optimized in this study allows to separately detect HHV6A/HHV6B and the main EBV types according to a unified laboratory protocol, whereas combining it with additional stage of DNA enrichment increases the diagnostic sensitivity of PCR analysis, minimizes proportion of discordant and false negative results. Such an integrated approach can be applied for diagnostic, epidemiological and research purposes.

Highlights

  • В современный период сохраняют высокую актуальность и медикосоциальную значимость инфекции и широкий спектр других нозологических форм заболеваний, в том числе онкологических, ассоциированных с вирусом

  • При концентрации ВГЧ6В

  • G.W., Geographical prevalence of two types of Epstein– Barr virus

Read more

Summary

Russian Journal of Infection and Immunity

ДЕТЕКЦИЯ ВЭБ1/ВЭБ2 И ВГЧ6А/ВГЧ6В DETECTION OF EBV1/EBV2 AND HHV6A/HHV6В aLaboratory of molecular biology and biotechnology, Academician I.N. В настоящее время сведения о генетической неоднородности ВЭБ, даже на уровне основных типов ВЭБ2), а также ВГЧ6А и ВГЧ6В, их распространенности и клиническом значении ограничиваются, главным образом, зарубежными данными. ВГЧ6А/ВГЧ6В в работе применялся оптимизированный однораундовый вариант ПЦР с электрофоретической детекцией продуктов амплификации в агарозном геле. Установлено, что среди обследованных детей Нижегородского региона в вирусной популяции преобладают ВЭБ1 и ВГЧ6В, что согласуется с существующими представлениями об их географическом распределении на прилегающих территориях. ВЭБ2 был обнаружен в единственном образце только в контрольной группе. Оптимизированный в данной работе методический подход позволяет раздельно детектировать ВЭБ1/ВЭБ2 и ВГЧ6А/ВГЧ6В по единому лабораторному протоколу, а в сочетании с дополнительным этапом концентрирования ДНК повышает диагностическую чувствительность ПЦРанализа, минимизирует долю дискордантных и ложноотрицательных результатов. Ключевые слова: ВЭБ1, ВЭБ2, ВГЧ6А, ВГЧ6В, вирусная нагрузка, ПЦР, генотипирование, дифференциальная детекция

Материалы и методы
Выделение ДНК
Результаты исследований
На этапе генотипирования ВЭБ нами проведена оптимизация условий
Обсуждение результатов
Positive control
Информация об авторах
Оригинальная статья
СПИСОК ЛИТЕРАТУРЫ
Subtypes in Bone Marrow Transplant

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.